Viewing StudyNCT00286793



Ignite Creation Date: 2024-05-05 @ 4:37 PM
Last Modification Date: 2024-10-26 @ 9:22 AM
Study NCT ID: NCT00286793
Status: COMPLETED
Last Update Posted: 2011-06-29
First Post: 2006-02-03

Brief Title: Safety and Efficacy Study of AT-101 in Combination With Docetaxel and Prednisone in Men With HRPC
Sponsor: Ascenta Therapeutics
Organization: Ascenta Therapeutics

Conditions & Keywords Data

Conditions:
Name
Prostate Cancer
Keywords:
Name View
prednisone View
at-101 View
at101 View
cancer View
hormone refractory View
prostate View
docetaxel View